Company intelligence / Profile preview

Ventrum

Cambridge, Massachusetts, USAventrum.com ↗

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Ventum Biotech's flagship product, Ventum One-Touch™, has demonstrated high efficacy against a broad spectrum of pathogens (LOG 6 reduction) and received EPA certification for its safety profile. It supports sterile environments across research labs, hospitals, emergency services, food production facilities, transportation hubs—anywhere rigorous hygiene standards are required.

Industry: Consumable Medical Devices

Partnerships

Works with strategic partners for scaling innovation; specific partner names not disclosed.Collaborates with institutions like CNRS and RNSA via scientific board members.

Beyond the preview

Go deeper on Ventrum.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ventrum.

Explore the full profile